No products in the cart.
Propranolol Hydrochloride Oral Solution
$1.00
Propranolol Hydrochloride Oral Solution (HeMeiJia) offers a sweet strawberry-mint 40mg/5mL formulation in a 40mL bottle. Approved by NMPA under H20213549, this solution provides accurate dosing—ideal for infantile hemangioma, pediatric cardiovascular, or pharmacokinetic studies.
Description
Propranolol Hydrochloride Oral Solution Description
Product name: Propranolol hydrochloride oral solution (Hemeijia)
Packaging specification: 40ml ? Product dosage form: oral solution Packaging unit: bottle/box
Approval number: National medicine standard H20213549 Drug code: 86903014000359
Manufacturer: Henan Centennial Kangxin Pharmaceutical Co., Ltd.
Product barcode: 6974909640008
Propranolol is a lipophilic non-selective adrenergic blocker with well-established use in managing cardiovascular conditions (hypertension, angina, essential tremor, migraine prophylaxis) and as first-line treatment for infantile hemangioma. In July 2021, the NMPA approved the first domestic 40mg/5mL strawberry-mint solution, branded HeMeiJia, which offers enhanced dose accuracy, palatability, and absorption consistency, crucial for sensitive dosing in infants.
Compared to tablets, this oral solution ensures a significantly better safety and efficacy profile in infants—87.9% effective vs. 74.6% with tablets—along with fewer side effects like diarrhea and sleep disturbances.
Propranolol Hydrochloride Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Propranolol Hydrochloride Oral Solution (HeMeiJia) |
| Concentration | 40mg per 5mL |
| Bottle Volume | 40mL |
| Flavor | Strawberry-mint |
| Dosage Form | Oral solution |
| Manufacturer | Henan Century Kangxin Pharmaceutical Co., Ltd. |
| Approval Number (NMPA) | H20213549 |
| Product Code | 86903014000359 |
| Barcode | 6974909640008 |
| Storage Conditions | Store at 20–25°C |
| Shelf Life | As specified on label |
| Presentation | Clear sweetened solution |
| Intended Use | Research or analytical purposes only |
Propranolol Hydrochloride Mechanism & Key Benefits
Blockade: Reduces heart rate, myocardial demand, tremor amplitude, and migraine frequency.
Infantile hemangioma treatment: Mechanism includes vasoconstriction, VEGF suppression, and endothelial apoptosis.
PK and safety: Sweetened solution ensures accurate dosing and avoids pulverizing errors, reducing GI irritation and improving compliance.
Why Choose HeMeiJia Solution?
Precise pediatric dosing without tablets or compounding
Sweet flavor increases compliance in sensitive populations
Proven clinical effectiveness and safety over tablets
Research-ready format ideal for pharmacology, PK, and safety studies
Summary
Propranolol Hydrochloride Oral Solution (HeMeiJia) offers a pediatric-friendly, accurate, and pleasant oral dosage form of propranolol. With strong clinical backing and regulatory approval, it’s perfect for preclinical studies, PK research, and dosage modeling.
Additional information
| Weight | 1.1 kg |
|---|---|
| Dimensions | 18 × 18 × 16 cm |
1 review for Propranolol Hydrochloride Oral Solution
Related products
Abiraterone Acetate Tablets (Hengrui) – 250mg
Abiraterone acetate is a potent CYP17A1 inhibitor used clinically to suppress androgen synthesis in prostate cancer. Manufactured by Chengdu Shengdi Pharmaceutical Co., Ltd., with China NMPA approval under H20193205 (product code: 86980435000069). This product is for laboratory research and development use only—not for clinical or therapeutic use. $2.00Elemene Injection
Elemene Injection is a traditional Chinese medicine–derived liposomal terpene mixture (elemene) approved in China (NMPA No. H20110114; Product Code 86909563000017). Supplied as a 10mL liposomal solution per vial (0.2g elemene), 5 vials per box. Intended strictly for laboratory and preclinical research purposes Please consult the staff for other purposes. $1.00Rilertinib Mesylate Tablets (Sanrisso) – 100mg
Rilertinib mesylate (Sanrisso), developed by Nanjing Sanhome Pharmaceutical Co., Ltd., is a third-generation EGFR-TKI approved by China's NMPA (Approval No. H20240020; Drug Code: 86901583000930). Each bottle contains 20 tablets of 100mg each. Strictly for laboratory research use only—not for clinical or human use. $1.00Temozolomide Capsules
Temozolomide 100mg capsules, 5 count box, produced by Shanghai ChuanNuo Pharmaceuticals Co., Ltd., approved under NMPA H20234716. A key alkylating agent for glioblastoma and astrocytoma research—ideal for preclinical oncology models. $1.00
nlibra –
Very good packaging, thank you